Hypercoagulable states.
Yardumian A, Machin SJ.
Int Anesthesiol Clin. 1985 Summer;23(2):141-55. doi: 10.1097/00004311-198523020-00012.
Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations.
Velásquez M, Rojas M, Abrahams VM, Escudero C, Cadavid ÁP.
Front Physiol. 2018 Dec 21;9:1840. doi: 10.3389/fphys.2018.01840. eCollection 2018.
Modern oral contraceptives and cardiovascular disease.
Rosenberg L, Palmer JR, Sands MI, Grimes D, Bergman U, Daling J, Mills A.
Am J Obstet Gynecol. 1997 Sep;177(3):707-15. doi: 10.1016/s0002-9378(97)70168-6.
Oral contraceptives: a reassessment.
Derman R.
Obstet Gynecol Surv. 1989 Sep;44(9):662-8. doi: 10.1097/00006254-198909000-00005.
Thrombotic disorders associated with pregnancy and the pill.
Tooke JE, McNicol GP.
Clin Haematol. 1981 Jun;10(2):613-30.
Hormonal contraceptive methods.
McEwan J.
Practitioner. 1985 May;229(1403):415-23.
[Chronic illness and contraception].
Saarikoski S.
Duodecim. 1987;103(9):593-7.
Clinical features and outcomes of peripartum obstetric patients admitted to the intensive care unit: A nationwide inpatient database in Japan.
Naruse S, Nakajima M, Aoki Y, Shigemi D, Kamijo K, Kaszynski RH, Ohbe H, Sasabuchi Y, Aso S, Matsui H, Fushimi K, Nakajima Y, Yasunaga H.
Crit Care. 2025 Aug 14;29(1):358. doi: 10.1186/s13054-025-05597-z.
Cardiovascular risks: perception versus reality.
Mishell DR Jr.
Contraception. 1999 Jan;59(1 Suppl):21S-24S. doi: 10.1016/s0010-7824(98)00133-4.
[Combined oral contraceptives].
Baulieu E, Ferin J, De Gennes JL, Netter A, Palmer R, Rozenbaum H.
Fertil Orthog. 1973 Jan;5(1):205-12.
